Skip to content

Inspire Medical Systems INSP Equity Method Investments

Equity Method Investments at other companies

LivaNova logo
LivaNovaLIVN
$18.49M
ITG
Integer HoldingsITGR
$20.23M+11,137%
ResMed logo
ResMedRMD
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's equity method investments?
Inspire Medical Systems (INSP) reported equity method investments of $115.88M in Q1 2026.
How has Inspire Medical Systems's equity method investments changed year-over-year?
Inspire Medical Systems's equity method investments increased by 158.5% year-over-year, from $44.83M to $115.88M.
What does equity method investments mean?
Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.